Skadden is advising Revance Therapeutics, while Kirkland & Ellis and Lowenstein Sandler are advising Crown Laboratories on the deal. Crown Laboratories, Inc., a privately held, global...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Hildred Capital in the transaction. Hildred Capital raised $750 million for its continuation fund to extend its ownership of two of its portfolio companies, Hyland’s...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Catalyst Investors on the transaction. Tava Health, Inc., a provider of virtual mental health and telehealth services to therapists and employee assistance programs,...
You must be a Standard 1 Year member to access this content.
Lowenstein represented First Wave BioPharma, Inc. in the transaction. First Wave BioPharma, Inc. (NASDAQ: FWBI), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Timber Pharmaceuticals, Inc. in the transaction. Timber Pharmaceuticals, Inc. (NYSE: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Big Health in the transaction. Big Health, the leading provider of non-drug digital treatments for mental health, announced the acquisition of Limbix, creators...
You must be a Standard 1 Year member to access this content.
Lowenstein represented Tonix Pharmaceuticals Holding Corp. in the transaction. Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), a clinical-stage biopharmaceutical company, announced its $25 million acquisition of two...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Traub Capital Partners in the transaction. Traub Capital Partners, a strategic private equity firm specializing in building value in consumer companies using its...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Coya Therapeutics in the transaction. Coya Therapeutics, Inc. (Nasdaq: COYA), a clinical-stage biotechnology company developing proprietary therapies to enhance the function of regulatory...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented LTS Lohmann Therapy Systems, Corp. in the transaction. LTS Lohmann Therapy Systems, Corp. (“LTS”) executed its acquisition of Tapemark Inc. (“Tapemark”) located in...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Crown Laboratories in the transaction. Crown Laboratories, Inc. (“Crown”), a leading, fully integrated global skincare company, announced its agreement with Eclipse MedCorp LLC,...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Signature Brands and its owner Traub Capital Partners in the transaction. Signature Brands, the leading North American manufacturer of dessert decorating products, announced...
You must be a Standard 1 Year member to access this content.
